Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Correlation between viral load, plasma levels of CD4 - CD8 T lymphocytes and AIDS-related oral diseases: a multicentre study on 30 HIV+ children in the HAART era.

Nesti M, Carli E, Giaquinto C, Rampon O, Nastasio S, Giuca MR.

J Biol Regul Homeost Agents. 2012 Jul-Sep;26(3):527-37.

PMID:
23034272
2.

Oral lesions and immune reconstitution syndrome in HIV+/AIDS patients receiving highly active antiretroviral therapy. Epidemiological evidence.

Gaitan Cepeda LA, Ceballos Salobreña A, López Ortega K, Arzate Mora N, Jiménez Soriano Y.

Med Oral Patol Oral Cir Bucal. 2008 Feb 1;13(2):E85-93.

3.

Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.

Sánchez-Ramón S, Bellón JM, Resino S, Cantó-Nogués C, Gurbindo D, Ramos JT, Muñoz-Fernández MA.

Pediatrics. 2003 Feb;111(2):E168-75.

PMID:
12563091
4.

Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.

Ortega KL, Vale DA, Magalhães MH.

J Oral Pathol Med. 2009 Jul;38(6):489-94. doi: 10.1111/j.1600-0714.2009.00783.x. Epub 2009 Apr 28.

PMID:
19453845
5.

Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.

Verweel G, van Rossum AM, Hartwig NG, Wolfs TF, Scherpbier HJ, de Groot R.

Pediatrics. 2002 Feb;109(2):E25.

PMID:
11826235
6.

Clinical outcomes and immune reconstitution in 103 advanced AIDS patients undergoing 12-month highly active antiretroviral therapy.

Dai Y, Qiu ZF, Li TS, Han Y, Zuo LY, Xie J, Ma XJ, Liu ZY, Wang AX.

Chin Med J (Engl). 2006 Oct 20;119(20):1677-82.

PMID:
17097013
7.

T-cell response of advanced aids patients after highly active antiretroviral therapy.

Wang AX, Li TS, Cao YZ, Han Y, Qiu ZF, Xie J.

Chin Med Sci J. 2005 Dec;20(4):223-5.

PMID:
16422247
8.

HPV oral lesions in HIV-infected patients: the impact of long-term HAART.

Anaya-Saavedra G, Flores-Moreno B, García-Carrancá A, Irigoyen-Camacho E, Guido-Jiménez M, Ramírez-Amador V.

J Oral Pathol Med. 2013 Jul;42(6):443-9. doi: 10.1111/jop.12032. Epub 2012 Dec 20.

PMID:
23278731
9.

Oral manifestations of an HIV positive cohort in the era of highly active anti-retroviral therapy (HAART) in South London.

Eyeson JD, Tenant-Flowers M, Cooper DJ, Johnson NW, Warnakulasuriya KA.

J Oral Pathol Med. 2002 Mar;31(3):169-74.

PMID:
11903824
10.
11.

The Changing Clinical Spectrum of Human Immunodeficiency Virus (HIV)-Related Oral Lesions in 1,000 Consecutive Patients: A 12-Year Study in a Referral Center in Mexico.

Ramírez-Amador V, Esquivel-Pedraza L, Sierra-Madero J, Anaya-Saavedra G, González-Ramírez I, Ponce-de-León S.

Medicine (Baltimore). 2003 Jan;82(1):39-50.

12.

Declining levels of rescued lymphoproliferative response to human cytomegalovirus (HCMV) in AIDS patients with or without HCMV disease following long-term HAART.

Gerna G, Piccinini G, Genini E, Percivalle E, Zavattoni M, Lilleri D, Testa L, Comolli G, Maserati R, Baldanti F, Maccario R, Monforte AD, Revello MG.

J Acquir Immune Defic Syndr. 2001 Dec 1;28(4):320-31.

PMID:
11707667
13.

Age-related immune reconstitution during highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children.

Hainaut M, Ducarme M, Schandene L, Peltier CA, Marissens D, Zissis G, Mascart F, Levy J.

Pediatr Infect Dis J. 2003 Jan;22(1):62-9.

PMID:
12544411
14.

Oral manifestations associated with HIV-related disease as markers for immune suppression and AIDS.

Glick M, Muzyka BC, Lurie D, Salkin LM.

Oral Surg Oral Med Oral Pathol. 1994 Apr;77(4):344-9.

PMID:
8015797
15.

Prevalence of oral lesions in HIV patients related to CD4 cell count and viral load in a Venezuelan population.

Bravo IM, Correnti M, Escalona L, Perrone M, Brito A, Tovar V, Rivera H.

Med Oral Patol Oral Cir Bucal. 2006 Jan 1;11(1):E33-9. English, Spanish.

16.
17.

Immune reconstitution in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy: a cohort study.

Johnston AM, Valentine ME, Ottinger J, Baydo R, Gryszowka V, Vavro C, Weinhold K, St Clair M, McKinney RE.

Pediatr Infect Dis J. 2001 Oct;20(10):941-6.

PMID:
11642627
18.

Oral lesions in Brazilian HIV-infected children undergoing HAART.

Miziara ID, Filho BC, Weber R.

Int J Pediatr Otorhinolaryngol. 2006 Jun;70(6):1089-96. Epub 2006 Jan 6.

PMID:
16406081
19.

[Oral manifestations, CD4+ T-lymphocytes count and viral load in Brazilian and North-American HIV-infected children].

Grando LJ, Yurgel LS, Machado DC, Silva CL, Menezes M, Picolli C.

Pesqui Odontol Bras. 2002 Jan-Mar;16(1):18-25. Portuguese.

PMID:
11938713
20.

Immunologic function and virologic suppression among children with perinatally acquired HIV Infection on highly active antiretroviral therapy.

Rutstein RM, Gebo KA, Flynn PM, Fleishman JA, Sharp VL, Siberry GK, Spector SA.

Med Care. 2005 Sep;43(9 Suppl):III15-22.

PMID:
16116305
Items per page

Supplemental Content

Write to the Help Desk